Article Information
History
- May 31, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Almudena Fuster-Matanzo†,1,*,
- Alfonso Picó Peris†,1,
- Fuensanta Bellvís Bataller1,
- Ana Jimenez-Pastor1,
- Glen J. Weiss2,
- Luis Martí-Bonmatí3,4,
- Antonio Lázaro Sánchez5,
- Giuseppe L. Banna6,
- Alfredo Addeo7 and
- Ángel Alberich-Bayarri1
- 1Quantitative Imaging Biomarkers in Medicine (Quibim), 46021 Valencia, Spain
- 2Quantitative Imaging Biomarkers in Medicine, Quibim, Boston, MA, USA, Boston, MA
- 3Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026, Valencia, Spain
- 4Área Clínica de Imagen Médica, Área Clínica de Imagen Médica, Hospital Universitari i Politècnic La Fe, Avinguda Fernando Abril Martorell, 106 Torre E planta 0, 46026, València, Spain
- 5Department of Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth, PO6 3LY, UK
- 6Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, PO1 2UP, UK
- 7University Hospital Geneva, Geneva, Switzerland
- ↵*Correspondence:
Almudena Fuster-Matanzo Quantitative Imaging Biomarkers in Medicine (Quibim), EDIFICIO EUROPA, Av. d’Aragó, 30, Planta 13 46021 Valencia, Spain Mail: almudenafuster{at}quibim.com Tel: +34 652124031
↵†These authors contributed equally to this work.
Posted May 31, 2024.
Prediction of oncogene mutation status in non-small cell lung cancer: A systematic review and meta-analysis with a special focus on artificial-intelligence-based methods
